The right drug, the right dose, for the right amount of time.
ID Health builds the technology to prescribe and manufacture personalized medicines on demand — safely, affordably, and at scale, with full traceability from raw material to finished dose.
One size never fits all. We make medicine that fits the person.
Doses set in clinical trials rarely match the real-world patients a drug is meant to help, yet only a handful of fixed strengths ever reach the market. ID Health makes it possible to manufacture truly individual treatment regimens — including combination therapies — at scale, just in time, close to the point of care.
Made on demand
Medicines prescribed and manufactured just in time, not stockpiled just in case — reducing waste, shortages and supply-chain fragility.
Truly personalized
Precise, patient-specific doses — and combination "polypills" that bring several medicines into a single, simpler course of treatment.
Traceable & safe
Every unit accountable from raw material to finished bottle, built to cGMP standards, with quality release in minutes rather than days.
Built around the person in the room.
Behind every personalized medicine is a conversation — a clinician and a patient working out what's right for them. ID Health gives that decision the means to deliver it: the exact treatment, made for one individual, when they need it.
Our vision for care →A breakthrough in capability, not just chemistry.
Personalized medicine, finally at scale.
We work with health systems, clinicians and partners to bring high-quality, affordable, personalized treatments to the patients who need them.
Get in touch →A broken one-size-fits-all system.
Modern medicine is manufactured for the average patient. But few of us are average — and the gap between the standard dose and the right dose is where harm, waste and poor outcomes accumulate.
Trial doses don't reflect real lives
The doses established in clinical trials often fail to represent the breadth of the real-world populations a drug is meant to help. After approval, only a limited number of fixed doses reach the market. For many patients that means too much, too little, or the wrong combination entirely.
When treatment can't flex to the person, the consequences compound: variable efficacy, adverse reactions, poor adherence, prescribing cascades, problematic polypharmacy, confusion, avoidable hospitalizations and wasted medicine.
Personalization has never been scalable.
Traditional compounding can tailor a medicine to a patient — but it's manual, slow, expensive and hard to scale, and its variable quality erodes trust. Health systems acknowledge the need for personalized medicines, yet lack the infrastructure to deliver them safely, effectively and at scale.
The standard model today
- — A few fixed doses for everyone
- — Reliance on cheap generic imports of variable quality
- — Manual, paper-based, siloed quality checks
- — "Just-in-case" stockpiling, waste and shortages
- — Little accountability when something goes wrong
The ID Health model
- → A dose designed around each individual patient
- → Manufactured to consistent, verifiable cGMP quality
- → Digitized, integrated, automated quality release
- → "Just-in-time" production, close to the patient
- → Full traceability for every single unit produced
This is the gap ID Health exists to close — turning personalization from a slow, artisanal exception into a fast, dependable standard.
How we do it →An automated, digitized platform for personalized manufacturing.
We transform production from manual to automated, from paper and siloed systems to integrated and digital, and from "just-in-case" to "just-in-time." Three breakthroughs, working as one platform.
DMEC — digital micro-dosing
Our core invention deposits an active ingredient and excipients rapidly and accurately, then compresses them into a personalized "mini-tablet." It's electronically controlled, with learning algorithms that change the dose from one dispense to the next and handle multiple formulations — so a production line can make a different medicine for every patient it serves.
PIMMS — the integrated platform
The Personalized Integrated Medicines Manufacturing System brings dosing, capsule filling, bottling, labeling and quality release together into one line. Built on five years of manufacturing learnings, it uses robotic automation, laser etching and visual inspection to produce personalized medicines — including polypills — just in time, with the ambition of 24/7 "lights-out" production in decentralized units.
Digital quality release & traceability
The bottleneck everyone else hits, solved. Our system digitizes and connects every quality check — from raw-material certificates of analysis through to the finished product — into a single source of truth, accessible from a unique identifier laser-etched onto each bottle. It removes manual document reconciliation, cuts quality release from days to minutes, and gives regulators unprecedented transparency and protection against counterfeits.
One line. A whole population.
A single, end-to-end, automated production line can manufacture personalized, fully traceable medicines for more than 120,000 patients a month — with same-day manufacture and quality release, and minimal human intervention.
Putting the patient at the center of care.
To be the first technology platform enabling the prescription and manufacture of high-quality, safe, personalized medicines — made on demand through a closed-loop model, with a relentless focus on patient outcomes.
The right drug, the right dose, for the right amount of time — and an engaged patient at the center of care.
Five commitments behind every dose.
Patients first
Every dose is designed around a person, not an average. Patient outcomes are the only measure that ultimately matters.
Safety without compromise
Personalization can never come at the cost of quality. cGMP standards are built into the platform, not bolted on.
Total traceability
Every unit is accountable from raw material to finished bottle. Nothing is hidden from patients, providers or regulators.
Access at scale
Precision medicine should be affordable and available to millions — not a privilege reserved for the few.
Engineering for trust
We build openly with regulators and clinical partners, and let evidence lead the way we grow.
Built for the hardest problems in everyday medicine.
Our platform applies wherever the standard dose fails the individual. We're beginning with two areas of high need and high impact, with a clear path into many more.
Mental health
Helping the many who struggle with side effects, dose reduction and safely coming off medication — by manufacturing the precise, gradually adjusted doses that careful deprescribing requires but standard tablets can't provide.
Cardiovascular disease
Improving adherence and outcomes for people managing complex medication regimens, by simplifying several daily medicines into a single personalized polypill tailored to the individual.
One platform, many unmet needs.
The same capability extends across pediatrics, metabolic conditions, hormone therapy and beyond — as well as manufacturing for adaptive clinical trials and integration with emerging delivery technologies. Wherever treatment needs to be precise, personal and properly traceable, the platform applies.
Starting where the need is greatest.
We're establishing our first manufacturing capability in close partnership with health systems, academic centers and clinical partners to bring personalized medicines into everyday care — and the growing market for high-quality compounded medicines is set to expand substantially through the rest of this decade.
Proven operators across pharmaceutical manufacturing, software, and venture building.
ID Health brings together deep experience in venture building, digital transformation and cGMP manufacturing — the disciplines it takes to turn personalized medicine from a promise into a production line.
Carlo Buckley
Former Baker & McKenzie M&A lawyer and co-founder of Mr Organic. Founder of ID Health.
David Kirby
Early-stage venture builder with an extensive business development background. Previously at Capgemini and Shell.
Rab Leckie
Specialist in operational technology, MES and digital transformation for pharma. Formerly at the CPI Medicines Manufacturing Innovation Centre.
Jim McGuire
Deep expertise in pharmaceutical manufacturing and operational technology. Formerly at the CPI Medicines Manufacturing Innovation Centre.
Let's bring personalized medicine to your patients.
We work with health systems, clinicians, researchers and partners who share our belief that the right dose should be available to everyone. We'd like to hear from you.